Frontiers in Cellular Neuroscience, 2019 · DOI: 10.3389/fncel.2019.00085 · Published: March 27, 2019
Multiple sclerosis (MS) damages the protective myelin sheath around nerve fibers in the central nervous system. The body can sometimes repair this damage through a process called remyelination, using cells called oligodendrocyte progenitor cells (OPCs). However, this repair often fails in advanced MS. This study investigates whether pericytes (PCs), cells surrounding blood vessels in the brain, can influence neural stem cells (NSCs) to become myelin-producing cells. They found that NSCs exposed to factors secreted by PCs were more likely to become oligodendrocytes, the cells that produce myelin. The researchers identified that a specific protein, Laminin alpha2 (Lama2), secreted by PCs, plays a crucial role in directing NSCs towards becoming oligodendrocytes rather than other types of brain cells like astrocytes. This suggests PCs and Lama2 could be potential targets for new MS therapies.
Pericytes and Lama2 could be targeted to develop new therapies promoting remyelination in MS.
The study provides insights into the mechanisms underlying CNS repair and the role of perivascular cells in this process.
Pericyte-based therapies could be explored to enhance oligodendrocyte production in demyelinating diseases.